Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA ...

Public health advocates have renewed calls for stronger public education and decisive policy action to improve awareness, promote early detection, expand access to care, and ensure sustained blood ...

Guideline adherence for opioid pain medications was found to be suboptimal among patients with sickle cell disease pain in the ED.

The Founder and Chief Executive Officer of CrimsonBow, Ms Timi Edwin, gave the commendation at the initiative’s ...

Sickle cell disease causes excruciating pain and damage to the body. But now there are new treatments that can put an end to ...

For years, my family struggled to understand the constant, mysterious pain my younger sister and I endured. Her cries were so frequent that she earned the nickname “Holly” because she was always ...

Only 1 in 3 patients in an ER for sickle cell crisis receive opioid painkillers within the first hour as treatment guidelines ...

For patients with acute sickle cell disease (SCD) pain presenting to the emergency department (ED), guideline adherence for delivery of opioid pain medications is inadequate, according to a study ...

Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...

In October 2024, Mercy’s newborn son was diagnosed with sickle cell disease, an inherited blood disorder caused by a mutation ...

Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...